BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

592 related articles for article (PubMed ID: 25618747)

  • 1. Skin barrier dysfunction measured by transepidermal water loss at 2 days and 2 months predates and predicts atopic dermatitis at 1 year.
    Kelleher M; Dunn-Galvin A; Hourihane JO; Murray D; Campbell LE; McLean WHI; Irvine AD
    J Allergy Clin Immunol; 2015 Apr; 135(4):930-935.e1. PubMed ID: 25618747
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transepidermal water loss measurement during infancy can predict the subsequent development of atopic dermatitis regardless of filaggrin mutations.
    Horimukai K; Morita K; Narita M; Kondo M; Kabashima S; Inoue E; Sasaki T; Niizeki H; Saito H; Matsumoto K; Ohya Y
    Allergol Int; 2016 Jan; 65(1):103-8. PubMed ID: 26666481
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Filaggrin mutations in relation to skin barrier and atopic dermatitis in early infancy.
    Hoyer A; Rehbinder EM; Färdig M; Asad S; Lødrup Carlsen KC; Endre KMA; Granum B; Haugen G; Hedlin G; Monceyron Jonassen C; Katayama S; Konradsen JR; Landrø L; LeBlanc M; Olsson Mägi CA; Rudi K; Skjerven HO; Staff AC; Vettukattil R; Bradley M; Nordlund B; Söderhäll C
    Br J Dermatol; 2022 Mar; 186(3):544-552. PubMed ID: 34698386
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Filaggrin loss-of-function mutations are associated with early-onset eczema, eczema severity and transepidermal water loss at 3 months of age.
    Flohr C; England K; Radulovic S; McLean WH; Campbel LE; Barker J; Perkin M; Lack G
    Br J Dermatol; 2010 Dec; 163(6):1333-6. PubMed ID: 21137118
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Atopic dermatitis and disease severity are the main risk factors for food sensitization in exclusively breastfed infants.
    Flohr C; Perkin M; Logan K; Marrs T; Radulovic S; Campbell LE; MacCallum SF; McLean WHI; Lack G
    J Invest Dermatol; 2014 Feb; 134(2):345-350. PubMed ID: 23867897
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Filaggrin loss-of-function mutations and levels of filaggrin degradation products in adult patients with atopic dermatitis in Croatia.
    Jurakic Toncic R; Kezic S; Jakasa I; Ljubojevic Hadzavdic S; Balic A; Petkovic M; Pavicic B; Zuzul K; Marinovic B
    J Eur Acad Dermatol Venereol; 2020 Aug; 34(8):1789-1794. PubMed ID: 31989686
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Skin barrier impairment at birth predicts food allergy at 2 years of age.
    Kelleher MM; Dunn-Galvin A; Gray C; Murray DM; Kiely M; Kenny L; McLean WHI; Irvine AD; Hourihane JO
    J Allergy Clin Immunol; 2016 Apr; 137(4):1111-1116.e8. PubMed ID: 26924469
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Raman profiles of the stratum corneum define 3 filaggrin genotype-determined atopic dermatitis endophenotypes.
    O'Regan GM; Kemperman PM; Sandilands A; Chen H; Campbell LE; Kroboth K; Watson R; Rowland M; Puppels GJ; McLean WH; Caspers PJ; Irvine AD
    J Allergy Clin Immunol; 2010 Sep; 126(3):574-80.e1. PubMed ID: 20621340
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Filaggrin breakdown products determine corneocyte conformation in patients with atopic dermatitis.
    Riethmuller C; McAleer MA; Koppes SA; Abdayem R; Franz J; Haftek M; Campbell LE; MacCallum SF; McLean WHI; Irvine AD; Kezic S
    J Allergy Clin Immunol; 2015 Dec; 136(6):1573-1580.e2. PubMed ID: 26071937
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Filaggrin loss-of-function variants are associated with atopic dermatitis phenotypes in a diverse, early-life prospective cohort.
    Virolainen SJ; Satish L; Biagini JM; Chaib H; Chang WC; Dexheimer PJ; Dixon MR; Dunn K; Fletcher D; Forney C; Granitto M; Hestand MS; Hurd M; Kauffman K; Lawson L; Martin LJ; Peña LD; Phelan KJ; Shook M; Weirauch MT; Khurana Hershey GK; Kottyan LC
    JCI Insight; 2024 Apr; 9(9):. PubMed ID: 38564302
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Filaggrin loss-of-function mutations are associated with enhanced expression of IL-1 cytokines in the stratum corneum of patients with atopic dermatitis and in a murine model of filaggrin deficiency.
    Kezic S; O'Regan GM; Lutter R; Jakasa I; Koster ES; Saunders S; Caspers P; Kemperman PM; Puppels GJ; Sandilands A; Chen H; Campbell LE; Kroboth K; Watson R; Fallon PG; McLean WH; Irvine AD
    J Allergy Clin Immunol; 2012 Apr; 129(4):1031-9.e1. PubMed ID: 22322004
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Severe skin inflammation and filaggrin mutation similarly alter the skin barrier in patients with atopic dermatitis.
    Mócsai G; Gáspár K; Nagy G; Irinyi B; Kapitány A; Bíró T; Gyimesi E; Tóth B; Maródi L; Szegedi A
    Br J Dermatol; 2014 Mar; 170(3):617-24. PubMed ID: 24251354
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sensitization to peanut, egg or pets is associated with skin barrier dysfunction in children with atopic dermatitis.
    Sherenian MG; Kothari A; Biagini JM; Kroner JW; Baatyrbek Kyzy A; Johannson E; Atluri G; He H; Martin LJ; Khurana Hershey GK
    Clin Exp Allergy; 2021 May; 51(5):666-673. PubMed ID: 33721370
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Moisturizing treatment of patients with atopic dermatitis and ichthyosis vulgaris improves dry skin, but has a modest effect on gene expression regardless of FLG genotype.
    Hoppe T; Winge MC; Bradley M; Nordenskjöld M; Vahlquist A; Törmä H; Berne B
    J Eur Acad Dermatol Venereol; 2015 Jan; 29(1):174-7. PubMed ID: 24330146
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Update on Epidemiology, Diagnosis, and Disease Course of Atopic Dermatitis.
    Simpson EL; Irvine AD; Eichenfield LF; Friedlander SF
    Semin Cutan Med Surg; 2016 Jun; 35(5 Suppl):S84-8. PubMed ID: 27525380
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predicting Skin Barrier Dysfunction and Atopic Dermatitis in Early Infancy.
    Rehbinder EM; Advocaat Endre KM; Lødrup Carlsen KC; Asarnoj A; Stensby Bains KE; Berents TL; Carlsen KH; Gudmundsdóttir HK; Haugen G; Hedlin G; Kreyberg I; Nordhagen LS; Nordlund B; Saunders CM; Sandvik L; Skjerven HO; Söderhäll C; Staff AC; Vettukattil R; Værnesbranden MR; Landrø L; ; Carlsen MH; Lødrup Carlsen OC; Granlund PA; Granum B; Götberg S; Hilde K; Jonassen CM; Nygaard UC; Rudi K; Skrindo I; Sjøborg K; Tedner SG; Wiik J; Winger AJ
    J Allergy Clin Immunol Pract; 2020 Feb; 8(2):664-673.e5. PubMed ID: 31568931
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Filaggrin genotype determines functional and molecular alterations in skin of patients with atopic dermatitis and ichthyosis vulgaris.
    Winge MC; Hoppe T; Berne B; Vahlquist A; Nordenskjöld M; Bradley M; Törmä H
    PLoS One; 2011; 6(12):e28254. PubMed ID: 22164253
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stratum corneum lipids, skin barrier function and filaggrin mutations in patients with atopic eczema.
    Jungersted JM; Scheer H; Mempel M; Baurecht H; Cifuentes L; Høgh JK; Hellgren LI; Jemec GB; Agner T; Weidinger S
    Allergy; 2010 Jul; 65(7):911-8. PubMed ID: 20132155
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tmem79/Matt is the matted mouse gene and is a predisposing gene for atopic dermatitis in human subjects.
    Saunders SP; Goh CS; Brown SJ; Palmer CN; Porter RM; Cole C; Campbell LE; Gierlinski M; Barton GJ; Schneider G; Balmain A; Prescott AR; Weidinger S; Baurecht H; Kabesch M; Gieger C; Lee YA; Tavendale R; Mukhopadhyay S; Turner SW; Madhok VB; Sullivan FM; Relton C; Burn J; Meggitt S; Smith CH; Allen MA; Barker JN; Reynolds NJ; Cordell HJ; Irvine AD; McLean WH; Sandilands A; Fallon PG
    J Allergy Clin Immunol; 2013 Nov; 132(5):1121-9. PubMed ID: 24084074
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Filaggrin loss-of-function mutations are not a predisposing factor for atopic dermatitis in an Ishigaki Island under subtropical climate.
    Sasaki T; Furusyo N; Shiohama A; Takeuchi S; Nakahara T; Uchi H; Hirota T; Tamari M; Shimizu N; Ebihara T; Amagai M; Furue M; Hayashi J; Kudoh J
    J Dermatol Sci; 2014 Oct; 76(1):10-5. PubMed ID: 25086748
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.